GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Price-to-Owner-Earnings

Deep Medicine Acquisition (Deep Medicine Acquisition) Price-to-Owner-Earnings : (As of Jun. 02, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Price-to-Owner-Earnings?

As of today (2024-06-02), Deep Medicine Acquisition's share price is $3.20. Deep Medicine Acquisition does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Deep Medicine Acquisition's Price-to-Owner-Earnings or its related term are showing as below:


DMAQ's Price-to-Owner-Earnings is not ranked *
in the Diversified Financial Services industry.
Industry Median: 5.75
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-02), Deep Medicine Acquisition's share price is $3.20. Deep Medicine Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.13. Therefore, Deep Medicine Acquisition's PE Ratio for today is At Loss.

As of today (2024-06-02), Deep Medicine Acquisition's share price is $3.20. Deep Medicine Acquisition's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.24. Therefore, Deep Medicine Acquisition's PE Ratio without NRI for today is At Loss.

During the past 3 years, Deep Medicine Acquisition's highest PE Ratio without NRI was 1306.67. The lowest was 0.00. And the median was 0.00.


Deep Medicine Acquisition Price-to-Owner-Earnings Historical Data

The historical data trend for Deep Medicine Acquisition's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Price-to-Owner-Earnings Chart

Deep Medicine Acquisition Annual Data
Trend Mar21 Mar22 Mar23
Price-to-Owner-Earnings
- - -

Deep Medicine Acquisition Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Deep Medicine Acquisition's Price-to-Owner-Earnings

For the Shell Companies subindustry, Deep Medicine Acquisition's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deep Medicine Acquisition's Price-to-Owner-Earnings Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's Price-to-Owner-Earnings falls into.



Deep Medicine Acquisition Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Deep Medicine Acquisition's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.20/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deep Medicine Acquisition  (NAS:DMAQ) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Deep Medicine Acquisition Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
595 Madison Avenue, 12th Floor, New York, NY, USA, 10017
Website
Deep Medicine Acquisition Corp is a blank check company.
Executives
John Chiang director 3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong director 2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen director, officer: Chief Executive Officer C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo officer: Chief Financial Officer 40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc 10 percent owner 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren director 7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires director 595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017

Deep Medicine Acquisition (Deep Medicine Acquisition) Headlines

From GuruFocus

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By Value_Insider Value_Insider 10-24-2022

Deep Medicine Acquisition Corp. Announces Appointment of a New Director

By GlobeNewswire GlobeNewswire 10-24-2022